Home/Filings/4/0001424422-16-000029
4//SEC Filing

BioPharmX Corp 4

Accession 0001424422-16-000029

CIK 0001504167operating

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 7:16 PM ET

Size

5.6 KB

Accession

0001424422-16-000029

Insider Transaction Report

Form 4
Period: 2016-07-21
Transactions
  • Award

    Option to purchase common stock

    2016-07-21$0.62/sh+65,000$40,300175,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
    Exercise: $0.62From: 2016-08-21Exp: 2026-07-21Common stock (65,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 12 months with the first vesting starting on 8/21/16.
  • [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001504167

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 7:16 PM ET
Size
5.6 KB